Literature DB >> 19166481

Endothelial CD200 is heterogeneously distributed, regulated and involved in immune cell-endothelium interactions.

Ya-Chen Ko1, Hsiung-Fei Chien, Ya-Fen Jiang-Shieh, Chiu-Yun Chang, Man-Hui Pai, Jian-Pei Huang, Hui-Min Chen, Ching-Hsiang Wu.   

Abstract

CD200 is a highly glycosylated cell surface protein containing two immunoglobulin superfamily domains in the extracellular region and performs immunosuppressive activities. It is widely distributed in various tissues including the vascular endothelium. We report here the distribution of CD200 in rat endothelia from different vascular beds. Endothelial CD200 immunoreactivity was weakly expressed in most arteries but was intensely expressed in the arterioles, most veins and venules, as well as continuous and fenestrated capillaries. The distribution of CD200 in the sinusoidal and lymphatic endothelia was variable. Immunoelectron microscopic studies revealed that endothelial CD200 varied considerably not only in different microvasculatures but also in the membrane domains at the subcellular level. Endothelial CD200 expression was differentially regulated by lipopolysaccharide in cell types both in vivo and in vitro. Functional assessments of endothelial CD200 suggested that the physical binding between CD200 and CD200 receptor (CD200R) was involved in T-cell adhesion to the endothelium but not in macrophage-endothelium interaction. In the latter, however, CD200 agonist, a synthetic peptide from complementarity-determining region 3 of mouse CD200, may trigger CD200R signaling in macrophages to suppress their adhesion to the endothelium. Our findings demonstrate that the distribution, subcellular localization, and lipopolysaccharide-regulation of endothelial CD200 are heterogeneous, and provide evidence elucidating the functional roles of endothelial CD200 during tissue inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19166481      PMCID: PMC2667927          DOI: 10.1111/j.1469-7580.2008.00986.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  45 in total

Review 1.  Endothelial cell heterogeneity.

Authors:  William C Aird
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

2.  Down-regulation of the macrophage lineage through interaction with OX2 (CD200).

Authors:  R M Hoek; S R Ruuls; C A Murphy; G J Wright; R Goddard; S M Zurawski; B Blom; M E Homola; W J Streit; M H Brown; A N Barclay; J D Sedgwick
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

3.  Endothelial cell diversity revealed by global expression profiling.

Authors:  Jen-Tsan Chi; Howard Y Chang; Guttorm Haraldsen; Frode L Jahnsen; Olga G Troyanskaya; Dustin S Chang; Zhen Wang; Stanley G Rockson; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

4.  Release of CXC-chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells.

Authors:  G C Beck; B A Yard; A J Breedijk; K Van Ackern; F J Van Der Woude
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

5.  The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans.

Authors:  G J Wright; M Jones; M J Puklavec; M H Brown; A N Barclay
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

6.  Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function.

Authors:  G J Wright; M J Puklavec; A C Willis; R M Hoek; J D Sedgwick; M H Brown; A N Barclay
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

7.  Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays.

Authors:  B Zhao; R A Bowden; S A Stavchansky; P D Bowman
Journal:  Am J Physiol Cell Physiol       Date:  2001-11       Impact factor: 4.249

8.  Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement.

Authors:  Francesca Fallarino; Carine Asselin-Paturel; Carmine Vacca; Roberta Bianchi; Stefania Gizzi; Maria Cristina Fioretti; Giorgio Trinchieri; Ursula Grohmann; Paolo Puccetti
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

9.  The same immunoregulatory molecules contribute to successful pregnancy and transplantation.

Authors:  Reginald M Gorczynski; Sima Hadidi; Gary Yu; David A Clark
Journal:  Am J Reprod Immunol       Date:  2002-07       Impact factor: 3.886

Review 10.  Molecular mechanisms of lymphangiogenesis in health and disease.

Authors:  Kari Alitalo; Peter Carmeliet
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

View more
  18 in total

1.  The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.

Authors:  Magda Stumpfova; Desirée Ratner; Edward B Desciak; Yehuda D Eliezri; David M Owens
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

Review 2.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

Review 3.  CD200-CD200R Pathway in the Regulation of Tumor Immune Microenvironment and Immunotherapy.

Authors:  Jin-Qing Liu; Aiyan Hu; Jianmin Zhu; Jianyu Yu; Fatemeh Talebian; Xue-Feng Bai
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  Reactive astrocytes promote adhesive interactions between brain endothelium and endothelial progenitor cells via HMGB1 and beta-2 integrin signaling.

Authors:  Kazuhide Hayakawa; Loc-Duyen D Pham; Ken Arai; Eng H Lo
Journal:  Stem Cell Res       Date:  2013-12-29       Impact factor: 2.020

5.  Newly Formed Endothelial Cells Regulate Myeloid Cell Activity Following Spinal Cord Injury via Expression of CD200 Ligand.

Authors:  Merav Cohen; Hila Ben-Yehuda; Ziv Porat; Catarina Raposo; Siamon Gordon; Michal Schwartz
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

6.  Distribution and expression of CD200 in the rat respiratory system under normal and endotoxin-induced pathological conditions.

Authors:  Ya-Fen Jiang-Shieh; Hsiung-Fei Chien; Chiu-Yun Chang; Tsui-Shan Wei; Mei-Miao Chiu; Hui-Min Chen; Ching-Hsiang Wu
Journal:  J Anat       Date:  2010-01-07       Impact factor: 2.610

7.  Systems approach to the pharmacological actions of HDAC inhibitors reveals EP300 activities and convergent mechanisms of regulation in diabetes.

Authors:  Haloom Rafehi; Antony Kaspi; Mark Ziemann; Jun Okabe; Tom C Karagiannis; Assam El-Osta
Journal:  Epigenetics       Date:  2017       Impact factor: 4.528

8.  The CD200 Regulates Inflammation in Mice Independently of TNF-α Production.

Authors:  Katarzyna Tonecka; Agata Braniewska; Zofia Pilch; Zuzanna Sas; Marcin Skorzynski; Elisabetta Manuali; Tomasz P Rygiel
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

9.  Aberrant CD200/CD200R1 expression contributes to painful synovium hyperplasia in a patient with primary hypertrophic osteoarthropathy.

Authors:  Yan Ren; Xiao-mei Leng; Bo Yang; Xuan Zhang
Journal:  Rheumatol Int       Date:  2013-04-18       Impact factor: 2.631

10.  The CD200-CD200 receptor inhibitory axis controls arteriogenesis and local T lymphocyte influx.

Authors:  Pleunie van den Borne; Tomasz P Rygiel; Ayla Hoogendoorn; Geertje H A Westerlaken; Louis Boon; Paul H A Quax; Gerard Pasterkamp; Imo E Hoefer; Linde Meyaard
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.